Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Automated iLet device from Beta Bionics manages blood-sugar levels with less user...

The agency that oversees the program is operating outside its legal lane to deny coverage of an innovative new...

  • 1575238880676450304 Profile photo of Madelyn

    Given the positive news today, on a drug that treats Alzheimer's through a novel mechanism; will Medicare reconsider the framework of its decision last year to effectively rebuff this category of drugs? Re-upping my op ed on that issue from January 2022. https://t.co/l9bZfvPi1H - view on twitter

Eisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of...

The new bivalent vaccine might be the first step in developing annual Covid shots, which could follow a similar process to the one used...

One possible way to help teenagers facing rising mental health issues: start school...

The measures would hit nearly $7 billion of Russian exports and ban the sale to Russia of new technologies, while the bloc will start...

Eisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of...

The pharmaceutical company allegedly used speaking and consulting fees to persuade doctors to prescribe its multiple sclerosis...

  • 1575065949669048321 Profile photo of Madelyn

    Biogen Inc. agreed to pay $900 million to settle allegations that it paid kickbacks to doctors to induce them to prescribe the company’s drugs, the Justice Department said https://t.co/dHnufOyO1u - view on twitter

Eisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of...